RVL Pharmaceuticals

RVL Pharmaceuticals

Pharmaceutical Manufacturing

Bridgewater, New Jersey 9,816 followers

About us

RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.

Industry
Pharmaceutical Manufacturing
Company size
201-500 employees
Headquarters
Bridgewater, New Jersey
Type
Public Company

Locations

Employees at RVL Pharmaceuticals

Updates

Similar pages

Browse jobs